CC SECURITIES (01375) achieved a first quarter net profit attributable to shareholders of 169 million yuan, representing a year-on-year increase of 63.8%.
Zhongzhou Securities (01375) released its performance for the first quarter of 2026, with operating income of 538 million yuan, a year-on-year increase of 34.04%; net profit attributable to shareholders of the listed company was 169 million yuan, a year-on-year increase of 63.8%; basic earnings per share were 0.0363 yuan.
CC Securities (01375) released its performance for the first quarter of 2026, with operating income of 538 million yuan, a year-on-year increase of 34.04%; net profit attributable to shareholders of the listed company was 169 million yuan, a year-on-year increase of 63.8%; basic earnings per share were 0.0363 yuan.
Related Articles
MICROPORT NEURO (02172) spent approximately HK$1.0348 million to repurchase 100,000 shares on April 29th.
Hansoh Pharma (03692): B7-H3 targeted antibody-drug conjugate HS-20093 approved as breakthrough therapy for castration-resistant prostate cancer.
.png)
Chongqing Sokon Industry Group Stock (09927) reported a first quarter net profit attributable to the parent company of 754 million yuan, an increase of 0.89% year-on-year.
MICROPORT NEURO (02172) spent approximately HK$1.0348 million to repurchase 100,000 shares on April 29th.
Hansoh Pharma (03692): B7-H3 targeted antibody-drug conjugate HS-20093 approved as breakthrough therapy for castration-resistant prostate cancer.
Chongqing Sokon Industry Group Stock (09927) reported a first quarter net profit attributable to the parent company of 754 million yuan, an increase of 0.89% year-on-year.
RECOMMEND
